These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22076435)

  • 1. Proteomic analysis reveals overexpression of moesin and cytokeratin 17 proteins in colorectal carcinoma.
    Kim CY; Jung WY; Lee HJ; Kim HK; Kim A; Shin BK
    Oncol Rep; 2012 Mar; 27(3):608-20. PubMed ID: 22076435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.
    Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW
    Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis shows down-regulations of cytoplasmic carbonic anhydrases, CAI and CAII, are early events of colorectal carcinogenesis but are not correlated with lymph node metastasis.
    Wang N; Chen Y; Han Y; Zhao Y; Liu Y; Guo K; Jiang Y
    Tumori; 2012 Nov; 98(6):783-91. PubMed ID: 23389367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinicopathological significance of REIC expression in colorectal carcinomas.
    Wang W; Zhu W; Xu XY; Nie XC; Yang X; Xing YN; Yu M; Liu YP; Takano Y; Zheng HC
    Histol Histopathol; 2012 Jun; 27(6):735-43. PubMed ID: 22473694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of IQGAP1 in advanced colorectal cancer correlates with poor prognosis-critical role in tumor invasion.
    Hayashi H; Nabeshima K; Aoki M; Hamasaki M; Enatsu S; Yamauchi Y; Yamashita Y; Iwasaki H
    Int J Cancer; 2010 Jun; 126(11):2563-74. PubMed ID: 19856315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput proteomics integrated with gene microarray for discovery of colorectal cancer potential biomarkers.
    Yu J; Li X; Zhong C; Li D; Zhai X; Hu W; Guo C; Yuan Y; Zheng S
    Oncotarget; 2016 Nov; 7(46):75279-75292. PubMed ID: 27661117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New prognosis biomarkers identified by dynamic proteomic analysis of colorectal cancer.
    Peng Y; Li X; Wu M; Yang J; Liu M; Zhang W; Xiang B; Wang X; Li X; Li G; Shen S
    Mol Biosyst; 2012 Nov; 8(11):3077-88. PubMed ID: 22996014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of GRP78 and GRP94 is involved in colorectal carcinogenesis.
    Takahashi H; Wang JP; Zheng HC; Masuda S; Takano Y
    Histol Histopathol; 2011 Jun; 26(6):663-71. PubMed ID: 21472681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MALDI imaging mass spectrometry reveals COX7A2, TAGLN2 and S100-A10 as novel prognostic markers in Barrett's adenocarcinoma.
    Elsner M; Rauser S; Maier S; Schöne C; Balluff B; Meding S; Jung G; Nipp M; Sarioglu H; Maccarrone G; Aichler M; Feuchtinger A; Langer R; Jütting U; Feith M; Küster B; Ueffing M; Zitzelsberger H; Höfler H; Walch A
    J Proteomics; 2012 Aug; 75(15):4693-704. PubMed ID: 22365974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between E-CD and Snail expressions and tumor invasion, metastasis and prognosis in colorectal cancer].
    Zheng BA; Deng GL; Dong QJ; Zhao ZS; Deng YC
    Zhonghua Zhong Liu Za Zhi; 2010 Feb; 32(2):111-6. PubMed ID: 20403241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic profiling of proteins associated with lymph node metastasis in colorectal cancer.
    Ma Y; Zhao M; Zhong J; Shi L; Luo Q; Liu J; Wang J; Yuan X; Huang C
    J Cell Biochem; 2010 Aug; 110(6):1512-9. PubMed ID: 20524204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and verification of gelsolin as a potential biomarker of colorectal adenocarcinoma in the Chinese population: Examining differential protein expression using an iTRAQ labelling-based proteomics approach.
    Fan NJ; Gao CF; Wang CS; Lv JJ; Zhao G; Sheng XH; Wang XL; Li DH; Liu QY; Yin J
    Can J Gastroenterol; 2012 Jan; 26(1):41-7. PubMed ID: 22288069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential proteomic analysis of human colorectal carcinoma cell lines metastasis-associated proteins.
    Zhao L; Liu L; Wang S; Zhang YF; Yu L; Ding YQ
    J Cancer Res Clin Oncol; 2007 Oct; 133(10):771-82. PubMed ID: 17503081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis of Tiam1-mediated metastasis in colorectal cancer.
    Liu L; Zhao L; Zhang Y; Zhang Q; Ding Y
    Cell Biol Int; 2007 Aug; 31(8):805-14. PubMed ID: 17376711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rat-to-human search for proteomic alterations reveals transgelin as a biomarker relevant to colorectal carcinogenesis and liver metastasis.
    Peng J; Zhang Q; Ma Y; Wang Y; Huang L; Zhang P; Chen J; Qin H
    Electrophoresis; 2009 Sep; 30(17):2976-2987. PubMed ID: 19711377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical assessment of ezrin and moesin in colorectal carcinoma.
    Abdou AG; Sakr S; Elwahed MM; Eladly EK
    Ultrastruct Pathol; 2016; 40(4):181-8. PubMed ID: 27042764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ezrin expression as a prognostic marker in colorectal adenocarcinoma.
    Patara M; Santos EM; Coudry Rde A; Soares FA; Ferreira FO; Rossi BM
    Pathol Oncol Res; 2011 Dec; 17(4):827-33. PubMed ID: 21465252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The proteomics of colorectal cancer: identification of a protein signature associated with prognosis.
    O'Dwyer D; Ralton LD; O'Shea A; Murray GI
    PLoS One; 2011; 6(11):e27718. PubMed ID: 22125622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker.
    Besson D; Pavageau AH; Valo I; Bourreau A; Bélanger A; Eymerit-Morin C; Moulière A; Chassevent A; Boisdron-Celle M; Morel A; Solassol J; Campone M; Gamelin E; Barré B; Coqueret O; Guette C
    Mol Cell Proteomics; 2011 Dec; 10(12):M111.009712. PubMed ID: 21986994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers.
    Alqurashi N; Gopalan V; Smith RA; Lam AK
    Hum Pathol; 2013 Oct; 44(10):2089-96. PubMed ID: 23773481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.